-
Tytuł:
-
Cryptic transmission of SARS-CoV-2 in Washington state.
-
Autorzy:
-
Bedford T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. .; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Greninger AL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Roychoudhury P; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Starita LM; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Famulare M; Institute for Disease Modeling, Bellevue, WA, USA.
Huang ML; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Nalla A; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Pepper G; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Reinhardt A; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Xie H; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Shrestha L; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Nguyen TN; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Adler A; Division of Infectious Disease, Seattle Children's Hospital, Seattle, WA, USA.
Brandstetter E; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
Cho S; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Giroux D; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Han PD; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Fay K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Frazar CD; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Ilcisin M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Lacombe K; Division of Infectious Disease, Seattle Children's Hospital, Seattle, WA, USA.
Lee J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Kiavand A; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Richardson M; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Sibley TR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Truong M; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Wolf CR; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
Nickerson DA; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Rieder MJ; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Englund JA; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Division of Infectious Disease, Seattle Children's Hospital, Seattle, WA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA.
Hadfield J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Hodcroft EB; Biozentrum, University of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Huddleston J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Molecular and Cellular Biology Program, University of Washington, Seattle, WA, USA.
Moncla LH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Müller NF; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Neher RA; Biozentrum, University of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Deng X; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Gu W; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Federman S; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Chiu C; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Duchin JS; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.; Public Health - Seattle & King County, Seattle, WA, USA.
Gautom R; Washington State Department of Health, Shoreline, WA, USA.
Melly G; Washington State Department of Health, Shoreline, WA, USA.
Hiatt B; Washington State Department of Health, Shoreline, WA, USA.
Dykema P; Washington State Department of Health, Shoreline, WA, USA.
Lindquist S; Washington State Department of Health, Shoreline, WA, USA.
Queen K; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Tao Y; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Uehara A; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Tong S; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
MacCannell D; Office of Advanced Molecular Detection, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Armstrong GL; Office of Advanced Molecular Detection, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Baird GS; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Chu HY; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
Shendure J; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.; Howard Hughes Medical Institute, Seattle, WA, USA.
Jerome KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
-
Corporate Authors:
-
Seattle Flu Study Investigators
-
Źródło:
-
Science (New York, N.Y.) [Science] 2020 Oct 30; Vol. 370 (6516), pp. 571-575. Date of Electronic Publication: 2020 Sep 10.
-
Typ publikacji:
-
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
-
Język:
-
English
-
Imprint Name(s):
-
Publication: : Washington, DC : American Association for the Advancement of Science
Original Publication: New York, N.Y. : [s.n.] 1880-
-
MeSH Terms:
-
Genome, Viral*
Betacoronavirus/*genetics
Coronavirus Infections/*epidemiology
Coronavirus Infections/*transmission
Pneumonia, Viral/*epidemiology
Pneumonia, Viral/*transmission
Bayes Theorem ; COVID-19 ; Humans ; Likelihood Functions ; Pandemics ; Phylogeny ; SARS-CoV-2 ; Washington/epidemiology
-
References:
-
mSphere. 2018 Jun 13;3(3):. (PMID: 29898986)
PLoS Comput Biol. 2013;9(3):e1002947. (PMID: 23555203)
J Mol Evol. 1985;22(2):160-74. (PMID: 3934395)
BMJ Open. 2020 Oct 7;10(10):e037295. (PMID: 33033018)
Mol Biol Evol. 2013 Apr;30(4):772-80. (PMID: 23329690)
Nat Med. 2020 Apr;26(4):450-452. (PMID: 32284615)
Int J Infect Dis. 2020 Apr;93:284-286. (PMID: 32145466)
J Clin Microbiol. 2016 Dec 28;55(1):177-182. (PMID: 27795347)
Cell. 2020 May 28;181(5):990-996.e5. (PMID: 32386545)
J Comput Biol. 2012 May;19(5):455-77. (PMID: 22506599)
Mol Biol Evol. 2015 Jan;32(1):268-74. (PMID: 25371430)
Glob Chall. 2017 Jan 10;1(1):33-46. (PMID: 31565258)
Lancet. 2020 Mar 21;395(10228):949. (PMID: 32087125)
Bioinformatics. 2014 Jul 15;30(14):2068-9. (PMID: 24642063)
Nat Microbiol. 2020 Nov;5(11):1403-1407. (PMID: 32669681)
N Engl J Med. 2020 Mar 26;382(13):1199-1207. (PMID: 31995857)
Virus Evol. 2018 Jun 08;4(1):vey016. (PMID: 29942656)
N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
BMC Genomics. 2018 Mar 20;19(1):204. (PMID: 29554870)
Clin Infect Dis. 2018 Jul 18;67(3):388-397. (PMID: 29432526)
Science. 2020 Jul 17;369(6501):297-301. (PMID: 32471856)
Science. 2020 May 1;368(6490):489-493. (PMID: 32179701)
N Engl J Med. 2020 Mar 5;382(10):929-936. (PMID: 32004427)
Bioinformatics. 2018 Dec 1;34(23):4121-4123. (PMID: 29790939)
Euro Surveill. 2017 Mar 30;22(13):. (PMID: 28382917)
-
Grant Information:
-
R21 AI129455 United States AI NIAID NIH HHS; RM1 HG010461 United States HG NHGRI NIH HHS; R35 GM119774 United States GM NIGMS NIH HHS; K08 CA230156 United States CA NCI NIH HHS; United Kingdom WT_ Wellcome Trust
-
Contributed Indexing:
-
Investigator: HY Chu; M Boeckh; JA Englund; M Famulare; BR Lutz; DA Nickerson; MJ Rieder; LM Starita; M Thompson; J Shendure; T Bedford; A Adler; E Brandstetter; S Cho; CD Frazar; D Giroux; PD Han; J Hadfield; S Huang; ML Jackson; A Kiavand; LE Kimball; K Lacombe; J Logue; V Lyon; KL Newman; M Richardson; TR Sibley; ML Zigman Suchsland; M Truong; CR Wolf
-
Entry Date(s):
-
Date Created: 20200911 Date Completed: 20201117 Latest Revision: 20210121
-
Update Code:
-
20240105
-
PubMed Central ID:
-
PMC7810035
-
DOI:
-
10.1126/science.abc0523
-
PMID:
-
32913002
-
After its emergence in Wuhan, China, in late November or early December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus rapidly spread globally. Genome sequencing of SARS-CoV-2 allows the reconstruction of its transmission history, although this is contingent on sampling. We analyzed 453 SARS-CoV-2 genomes collected between 20 February and 15 March 2020 from infected patients in Washington state in the United States. We find that most SARS-CoV-2 infections sampled during this time derive from a single introduction in late January or early February 2020, which subsequently spread locally before active community surveillance was implemented.
(Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)
Update of: medRxiv. 2020 Apr 06;:. (PMID: 32511596)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.
